Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early-onset anemia after kidney transplantation is an independent factor for graft loss: a multicenter, observational cohort study.
Pascual J, Jiménez C, Franco A, Gil M, Obrador-Mulet AR, Gentil MA, Romero R, Grinyó JM, Hernández D, Morales JM, Pallardó LM, Serón D, Arias M, Campistol JM; ANEMIART Study Group. Pascual J, et al. Among authors: gentil ma. Transplantation. 2013 Oct 27;96(8):717-25. doi: 10.1097/TP.0b013e31829f162e. Transplantation. 2013. PMID: 23896555
Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation: a Spanish multicenter study.
González Molina M, Serón D, García del Moral R, Carrera M, Sola E, Gómez Ullate P, Capdevila L, Gentil MA; Spanish Mycophenolate Mofetil and Chronic Graft Nephropathy Study Group. González Molina M, et al. Among authors: gentil ma. Transplant Proc. 2002 Feb;34(1):335-7. doi: 10.1016/s0041-1345(01)02788-9. Transplant Proc. 2002. PMID: 11959313 Clinical Trial. No abstract available.
Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
Gonzalez Molina M, Seron D, Garcia del Moral R, Carrera M, Sola E, Jesus Alferez M, Gomez Ullate P, Capdevila L, Gentil MA. Gonzalez Molina M, et al. Among authors: gentil ma. Transplantation. 2004 Jan 27;77(2):215-20. doi: 10.1097/01.TP.0000100684.59784.FF. Transplantation. 2004. PMID: 14742984 Clinical Trial.
Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age.
Osuna A, Gentil MA, Capdevila L, Cantarell C, Mazuecos A, Pereira P, Rodríguez-Algarra G, González-Molina M; Spanish Kidney Transplant of Elderly Donor Study Group. Osuna A, et al. Among authors: gentil ma. Transplant Proc. 2005 Apr;37(3):1438-40. doi: 10.1016/j.transproceed.2005.02.039. Transplant Proc. 2005. PMID: 15866630 Clinical Trial.
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients.
Guirado L, Cantarell C, Franco A, Huertas EG, Fructuoso AS, Fernández A, Gentil MA, Rodríguez A, Paul J, Torregrossa JV, Rodríguez A, Alonso A, Hernández D, Burgos D, Jiménez C, Jimeno L, Lauzurica R, Mazuecos A, Osuna A, Plumed JS, Ruiz JC, Zárraga S; GREAT Study Group. Guirado L, et al. Among authors: gentil ma. Am J Transplant. 2011 Sep;11(9):1965-71. doi: 10.1111/j.1600-6143.2011.03571.x. Epub 2011 Jun 10. Am J Transplant. 2011. PMID: 21668633 Free article. Clinical Trial.
89 results